127 related articles for article (PubMed ID: 7624836)
21. The arterial antithrombotic activity of thioxylosides in a rat model of laser-induced thrombosis.
Aguejouf O; Oualane FA; Inamo J; Imbault P; Doutremepuich F; Millet J; Theveniaux J; Doutremepuich C
Semin Thromb Hemost; 1996; 22(4):327-33. PubMed ID: 8944417
[TBL] [Abstract][Full Text] [Related]
22. Calin--a platelet adhesion inhibitor from the saliva of the medicinal leech.
Munro R; Jones CP; Sawyer RT
Blood Coagul Fibrinolysis; 1991 Feb; 2(1):179-84. PubMed ID: 1772988
[TBL] [Abstract][Full Text] [Related]
23. Structural insights into thrombolytic activity of destabilase from medicinal leech.
Marin E; Kornilov DA; Bukhdruker SS; Aleksenko VA; Manuvera VA; Zinovev EV; Kovalev KV; Shevtsov MB; Talyzina AA; Bobrovsky PA; Kuzmichev PK; Mishin AV; Gushchin IY; Lazarev VN; Borshchevskiy VI
Sci Rep; 2023 Apr; 13(1):6641. PubMed ID: 37095116
[TBL] [Abstract][Full Text] [Related]
24. A stable prostacyclin-like substance produced by the medicinal leech Hirudo medicinalis.
Nikonov GI; Titova EA; Seleznev KG
Prostaglandins Other Lipid Mediat; 1999 Aug; 58(1):1-7. PubMed ID: 10482282
[TBL] [Abstract][Full Text] [Related]
25. [Hydrolysis of the isopeptide epsilon-(gamma-glutamyl)-lysine by destabilase from the medicinal leech Hirudo medicinalis].
Baskova IP; Timokhina EA; Nikonov GI; Stepanov VM
Biokhimiia; 1990 May; 55(5):771-5. PubMed ID: 2203479
[TBL] [Abstract][Full Text] [Related]
26. Effect of age of Armagnac extract and duration of treatment on antithrombotic effects in a rat thrombosis model.
Umar A; Boisseau M; Segur MC; Begaud B; Moore N
Thromb Res; 2003; 111(3):185-9. PubMed ID: 14678818
[TBL] [Abstract][Full Text] [Related]
27. Generation of recombinant destabilase-lysozyme from medicinal leeches in three different expression systems.
Manuvera VA; Kurdyumov AS; Filonova KA; Lazarev VN
Protein Expr Purif; 2015 Dec; 116():50-8. PubMed ID: 26277552
[TBL] [Abstract][Full Text] [Related]
28. Antithrombotic effects of orally active synthetic antagonist of activated factor X in nonhuman primates.
Yokoyama T; Kelly AB; Marzec UM; Hanson SR; Kunitada S; Harker LA
Circulation; 1995 Aug; 92(3):485-91. PubMed ID: 7634464
[TBL] [Abstract][Full Text] [Related]
29. A PAF-acether antagonist (N 48740 RP/Rhône-Poulenc) and laser-induced thrombi in rat mesenteric vessels.
Weichert W; Breddin HK
Haemostasis; 1989; 19(4):229-34. PubMed ID: 2807041
[TBL] [Abstract][Full Text] [Related]
30. [Highly active fractions of the medicinal leech recombinant destabilase-lysozyme].
Fadeeva IuI; Antipova NV; Baskova IP; Zavalova LL
Biomed Khim; 2014; 60(3):332-7. PubMed ID: 25019395
[TBL] [Abstract][Full Text] [Related]
31. Antithrombotic activity of NSP-513, a novel selective phosphodiesterase 3 inhibitor, on femoral arterial thrombosis induced by physical stenosis and electrical current: comparison of antithrombotic and hemodynamic effects.
Hirose H; Mashiko S; Kimura T; Ishida F; Mochizuki N; Nishibe T; Nishikibe M
J Cardiovasc Pharmacol; 2000 Apr; 35(4):586-94. PubMed ID: 10774790
[TBL] [Abstract][Full Text] [Related]
32. A thromboxane A2/prostaglandin H2 receptor antagonist (S18886) shows high antithrombotic efficacy in an experimental model of stent-induced thrombosis.
Vilahur G; Casaní L; Badimon L
Thromb Haemost; 2007 Sep; 98(3):662-9. PubMed ID: 17849057
[TBL] [Abstract][Full Text] [Related]
33. Synergistic antithrombotic properties of G4120, a RGD-containing synthetic peptide, and argatroban, a synthetic thrombin inhibitor, in a hamster femoral vein platelet-rich thrombosis model.
Imura Y; Stassen JM; Vreys I; Lesaffre E; Gold HK; Collen D
Thromb Haemost; 1992 Sep; 68(3):336-40. PubMed ID: 1440501
[TBL] [Abstract][Full Text] [Related]
34. [Kinetics of L-gamma-Glu-pNA hydrolysis by destabilase, the enzyme from the medicinal leech Hirudo medicinalis].
Baskova IP; Nikonov GI; Zavalova LL; Larionova NI
Biokhimiia; 1990 Apr; 55(4):674-9. PubMed ID: 2198950
[TBL] [Abstract][Full Text] [Related]
35. Antithrombotic activities of aqueous extract from Gardenia jasminoides and its main constituent.
Zhang HY; Liu H; Yang M; Wei SF
Pharm Biol; 2013 Feb; 51(2):221-5. PubMed ID: 23116215
[TBL] [Abstract][Full Text] [Related]
36. [The hydrolysis of Glu(gamma-epsilon)Lys-amide bonds in D-dimer fragment of fibrin by destabilase from medicinal leech].
Baskova IP; Zavalova LL; Basanova AV; Grigor'eva OV
Bioorg Khim; 1999 Jun; 25(6):435-8. PubMed ID: 10505231
[TBL] [Abstract][Full Text] [Related]
37. Comparison of the inhibitory effects of the TXA2 receptor antagonist, vapiprost, and other antiplatelet drugs on arterial thrombosis in rats: possible role of TXA2.
Takiguchi Y; Wada K; Nakashima M
Thromb Haemost; 1992 Oct; 68(4):460-3. PubMed ID: 1448780
[TBL] [Abstract][Full Text] [Related]
38. Experimental thrombosis on a collagen coated arterioarterial shunt in rats: a pharmacological model to study antithrombotic agents inhibiting thrombin formation and platelet deposition.
Freund M; Mantz F; Nicolini P; Gachet C; Mulvihill J; Meyer L; Beretz A; Cazenave JP
Thromb Haemost; 1993 May; 69(5):515-21. PubMed ID: 8322274
[TBL] [Abstract][Full Text] [Related]
39. The antithrombotic effect of aurin tricarboxylic acid in the guinea pig is not solely due to its interaction with the von Willebrand factor-GPIb axis.
Azzam K; Cissé-Thiam M; Drouet L
Thromb Haemost; 1996 Jan; 75(1):203-10. PubMed ID: 8713802
[TBL] [Abstract][Full Text] [Related]
40. YC-1, a nitric oxide-independent activator of soluble guanylate cyclase, inhibits platelet-rich thrombosis in mice.
Teng CM; Wu CC; Ko FN; Lee FY; Kuo SC
Eur J Pharmacol; 1997 Feb; 320(2-3):161-6. PubMed ID: 9059849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
